{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:30:46Z","timestamp":1790688646284,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:00:00Z","timestamp":1399248000000},"content-version":"vor","delay-in-days":947,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1593\/neo.11138","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T13:11:02Z","timestamp":1429794662000},"page":"899-IN16","source":"Crossref","is-referenced-by-count":67,"title":["Molecular Requirements for Transformation of Fallopian Tube Epithelial Cells into Serous Carcinoma"],"prefix":"10.1016","volume":"13","author":[{"given":"Amir A.","family":"Jazaeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neetu","family":"Dahiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark H.","family":"Stoler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Stuart","family":"Ferriss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anindya","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1593\/neo.11138_bib1","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.ajog.2006.03.006","article-title":"Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy","volume":"194","author":"Lamb","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1593\/neo.11138_bib2","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1002\/cncr.22603","article-title":"Prophylactic salpingo-oophorectomy in a series of 89 women carrying a BRCA1 or a BRCA2 mutation","volume":"109","author":"Laki","year":"2007","journal-title":"Cancer"},{"key":"10.1593\/neo.11138_bib3","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":"Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.11138_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3121\/cmr.2007.702","article-title":"Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer","volume":"5","author":"Crum","year":"2007","journal-title":"Clin Med Res"},{"key":"10.1593\/neo.11138_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ygyno.2009.01.013","article-title":"Precursors to pelvic serous carcinoma and their clinical implications","volume":"113","author":"Folkins","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1593\/neo.11138_bib6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":"A candidate precursor to serous carcinoma that originates in the distal fallopian tube","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"10.1593\/neo.11138_bib7","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0090-8258(03)00365-2","article-title":"BRCA1\/2-related ovarian cancers are of tubal origin: a hypothesis","volume":"90","author":"Piek","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1593\/neo.11138_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2008.01.012","article-title":"A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations","volume":"109","author":"Folkins","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1593\/neo.11138_bib9","doi-asserted-by":"crossref","first-page":"5261","DOI":"10.1002\/cncr.25439","article-title":"The molecular pathogenesis of hereditary ovarian carcinoma: alterations in the tubal epithelium of women with BRCA1 and BRCA2 mutations","volume":"116","author":"Norquist","year":"2010","journal-title":"Cancer"},{"key":"10.1593\/neo.11138_bib10","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2009.89","article-title":"Candidate serous cancer precursors in fallopian tube epithelium of BRCA1\/2 mutation carriers","volume":"22","author":"Shaw","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1593\/neo.11138_bib11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nmeth1104-163","article-title":"Cloning of short hairpin RNAs for gene knockdown in mammalian cells","volume":"1","author":"Paddison","year":"2004","journal-title":"Nat Methods"},{"key":"10.1593\/neo.11138_bib12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/nrc2946","article-title":"The genesis and evolution of high-grade serous ovarian cancer","volume":"10","author":"Bowtell","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1593\/neo.11138_bib13","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1017\/S146239940800077X","article-title":"Critical molecular abnormalities in high-grade serous carcinoma of the ovary","volume":"10","author":"Kobel","year":"2008","journal-title":"Expert Rev Mol Med"},{"key":"10.1593\/neo.11138_bib14","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1158\/0008-5472.CAN-05-1543","article-title":"A network of genetic events sufficient to convert normal human cells to a tumorigenic state","volume":"65","author":"Kendall","year":"2005","journal-title":"Cancer Res"},{"key":"10.1593\/neo.11138_bib15","doi-asserted-by":"crossref","first-page":"7773","DOI":"10.1038\/sj.onc.1210881","article-title":"DNA damage signalling guards against activated oncogenes and tumour progression","volume":"26","author":"Bartek","year":"2007","journal-title":"Oncogene"},{"key":"10.1593\/neo.11138_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2010.03.012","article-title":"Molecular characterization of ovarian cancer by gene-expression profiling","volume":"118","author":"Gomez-Raposo","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1593\/neo.11138_bib17","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/jnci\/94.13.990","article-title":"Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers","volume":"94","author":"Jazaeri","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1593\/neo.11138_bib18","first-page":"4811","article-title":"Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies","volume":"9","author":"Zorn","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1593\/neo.11138_bib19","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1073\/pnas.98.3.1176","article-title":"Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer","volume":"98","author":"Welsh","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.11138_bib20","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1128\/MCB.12.12.5581","article-title":"Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding","volume":"12","author":"Shaulian","year":"1992","journal-title":"Mol Cell Biol"},{"key":"10.1593\/neo.11138_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1568009053332627","article-title":"MDM2 is a central node in the p53 pathway: 12 years and counting","volume":"5","author":"Bond","year":"2005","journal-title":"Curr Cancer Drug Targets"},{"key":"10.1593\/neo.11138_bib22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2008.05.001","article-title":"Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer","volume":"69","author":"Gadducci","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1593\/neo.11138_bib23","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1002\/j.1460-2075.1996.tb01050.x","article-title":"Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-myc","volume":"15","author":"Vlach","year":"1996","journal-title":"EMBO J"},{"key":"10.1593\/neo.11138_bib24","doi-asserted-by":"crossref","first-page":"8065","DOI":"10.1158\/0008-5472.CAN-07-1515","article-title":"Identification of an integrated SV40 T\/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis","volume":"67","author":"Deeb","year":"2007","journal-title":"Cancer Res"},{"key":"10.1593\/neo.11138_bib25","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1073\/pnas.1017300108","article-title":"Modeling high-grade serous ovarian carcinogenesis from the fallopian tube","volume":"108","author":"Karst","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.11138_bib26","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ncb1110","article-title":"A signalling pathway controlling c-myc degradation that impacts oncogenic transformation of human cells","volume":"6","author":"Yeh","year":"2004","journal-title":"Nat Cell Biol"},{"key":"10.1593\/neo.11138_bib27","doi-asserted-by":"crossref","first-page":"32529","DOI":"10.1074\/jbc.M110.151902","article-title":"p27Kip1 mediates addiction of ovarian cancer cells to MYCC (c-MYC) and their dependence on MYC paralogs","volume":"285","author":"Prathapam","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1593\/neo.11138_bib28","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1091\/mbc.E03-05-0279","article-title":"Gene expression patterns in ovarian carcinomas","volume":"14","author":"Schaner","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1593\/neo.11138_bib29","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/modpathol.2011.3","article-title":"PAX 8 expression in non-neoplastic tissues, primary tumors, and metastatic tumors: a comprehensive immunohistochemical study","volume":"24","author":"Ozcan","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1593\/neo.11138_bib30","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/modpathol.3800612","article-title":"Comprehensive analysis of HE4 expression in normal and malignant human tissues","volume":"19","author":"Galgano","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1593\/neo.11138_bib31","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1038\/onc.2009.402","article-title":"Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis","volume":"29","author":"Levanon","year":"2010","journal-title":"Oncogene"},{"key":"10.1593\/neo.11138_bib32","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":"Emerging roles for PAX8 in ovarian cancer and endosalpingeal development","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1593\/neo.11138_bib33","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1593\/neo.11138_bib34","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact","volume":"26","author":"Levanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1593\/neo.11138_bib35","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1095\/biolreprod.109.078329","article-title":"Reconstruction of oviduct and demonstration of epithelial fate determination in mice","volume":"82","author":"Yamanouchi","year":"2010","journal-title":"Biol Reprod"},{"key":"10.1593\/neo.11138_bib36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1593\/neo.101720","article-title":"Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer","volume":"13","author":"Schauer","year":"2011","journal-title":"Neoplasia"},{"key":"10.1593\/neo.11138_bib37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1593\/neo.91948","article-title":"Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer","volume":"12","author":"Lawrenson","year":"2010","journal-title":"Neoplasia"},{"key":"10.1593\/neo.11138_bib38","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrc2693","article-title":"When mutants gain new powers: news from the mutant p53 field","volume":"9","author":"Brosh","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1593\/neo.11138_bib39","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1128\/MCB.22.7.2111-2123.2002","article-title":"Enumeration of the simian virus 40 early region elements necessary for human cell transformation","volume":"22","author":"Hahn","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1593\/neo.11138_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":"Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary","volume":"221","author":"Ahmed","year":"2010","journal-title":"J Pathol"},{"key":"10.1593\/neo.11138_bib41","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.1088759","article-title":"Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2","volume":"302","author":"King","year":"2003","journal-title":"Science"},{"key":"10.1593\/neo.11138_bib42","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2407-8-17","article-title":"Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities","volume":"8","author":"Press","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1593\/neo.11138_bib43","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nature03845","article-title":"Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants","volume":"436","author":"Hemann","year":"2005","journal-title":"Nature"},{"key":"10.1593\/neo.11138_bib44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/IGC.0b013e31820986e5","article-title":"Prognostic impact of p53, p27, and C-MYC on clinicopathological features and outcome in early-stage (FigO I-II) epithelial ovarian cancer","volume":"21","author":"Skirnisdottir","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1593\/neo.11138_bib45","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ng.668","article-title":"A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24","volume":"42","author":"Goode","year":"2010","journal-title":"Nat Genet"},{"key":"10.1593\/neo.11138_bib46","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/gcc.20356","article-title":"Chromosomal losses of regions on 5q and lack of high-level amplifications at 8q24 are associated with favorable prognosis for ovarian serous carcinoma","volume":"45","author":"Staebler","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1593\/neo.11138_bib47","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.4161\/cc.5.10.2734","article-title":"Genetically engineered human cancer models utilizing mammalian transgene expression","volume":"5","author":"Kendall","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1593\/neo.11138_bib48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-0-387-68969-2_9","article-title":"Role of p53 and Rb in ovarian cancer","volume":"622","author":"Corney","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"10.1593\/neo.11138_bib49","doi-asserted-by":"crossref","first-page":"14723","DOI":"10.1073\/pnas.95.25.14723","article-title":"Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization","volume":"95","author":"Counter","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1593\/neo.11138_bib50","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1016\/j.febslet.2010.05.026","article-title":"Telomeres and telomerase in normal and cancer stem cells","volume":"584","author":"Shay","year":"2010","journal-title":"FEBS Lett"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558611800783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558611800783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T07:15:29Z","timestamp":1598944529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558611800783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S1476558611800783"],"URL":"https:\/\/doi.org\/10.1593\/neo.11138","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}